News

Advanced Therapies,Drug Discovery & Development,Genomics and sequencing
Broken String Biosciences launches BaseMap ABE for genome-wide off-target analysis
read more
Central Nervous System,Drug Discovery & Development,Research & Development
AstronauTx exercises Saniona option for neurological disease candidate
read more
Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain,Research & Development
European consortium demonstrates continuous API manufacturing platform
read more
Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development
BioVie reports Phase 2 Parkinson’s trial results for bezisterim
read more
Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Research & Development
LifeMine raises $263 million to advance transplant rejection therapy into Phase 2
read more
Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas
Kupando doses first patient in Phase 1 trial of KUP101 for advanced skin cancer
read more
Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics
Adneuris licenses cebranopadol to Maruishi in $35M Japan and South Korea deal
read more
Clinical & Regulatory,Medical devices,Therapeutic Areas
BlueWind wins FDA clearance for longer-lasting Revi implant for urinary incontinence
read more
Digital & Data,Drug Discovery & Development,Research & Development
AI virtual screening tool boosts hit rate 100-fold on challenging drug targets
read more
Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
FDA backs registration pathway for Obsidian’s melanoma TIL therapy
read more
Central Nervous System,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
AC Immune advances Parkinson’s and Alzheimer’s pipeline with key clinical milestones ahead
read more
Drug Discovery & Development,Genomics and sequencing,Research & Development
NEB launches cell-free RNA extraction kit for liquid biopsy research Slug: neb-c
read more
Central Nervous System,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
ABLi reports biomarker changes supporting disease-modifying potential of Parkinson’s drug
read more
Biotech & Pharma Business,Digital & Data,Drug Discovery & Development
Norstella launches agentic AI platform for biopharma decision-making
read more
Digital & Data,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
AI model cuts radiopharmaceutical dose mapping to seconds in prostate cancer study
read more
Drug Delivery & Formulation,Manufacturing & Supply Chain,Research & Development
Piramal Pharma Solutions expands peptide API facility with spray drying suite
read more

Broken String Biosciences launches BaseMap ABE for genome-wide off-target analysis

AstronauTx exercises Saniona option for neurological disease candidate

European consortium demonstrates continuous API manufacturing platform

BioVie reports Phase 2 Parkinson’s trial results for bezisterim

LifeMine raises $263 million to advance transplant rejection therapy into Phase 2

Kupando doses first patient in Phase 1 trial of KUP101 for advanced skin cancer

Adneuris licenses cebranopadol to Maruishi in $35M Japan and South Korea deal

BlueWind wins FDA clearance for longer-lasting Revi implant for urinary incontinence

AI virtual screening tool boosts hit rate 100-fold on challenging drug targets

FDA backs registration pathway for Obsidian’s melanoma TIL therapy

AC Immune advances Parkinson’s and Alzheimer’s pipeline with key clinical milestones ahead

NEB launches cell-free RNA extraction kit for liquid biopsy research Slug: neb-c

ABLi reports biomarker changes supporting disease-modifying potential of Parkinson’s drug

Norstella launches agentic AI platform for biopharma decision-making

AI model cuts radiopharmaceutical dose mapping to seconds in prostate cancer study

Piramal Pharma Solutions expands peptide API facility with spray drying suite

main menu

recent posts

Researchers develop human iPS cell model of heart failure

Resolution Therapeutics completes Phase 1/2 RTX001 liver disease trial dosing

Eleva separates biologics platform from Factor H therapy

get connected